SCHEDULE: Vanguard Group Adjusts CareDx Inc. Ownership Reporting

The Vanguard Group reported a 0% beneficial ownership in CareDx Inc. following an internal realignment that disaggregates its reporting.

Summary

• The Vanguard Group filed an Amendment No. 9 to its Schedule 13G for CareDx Inc.
• The filing indicates that The Vanguard Group now holds 0% beneficial ownership of CareDx Inc. common stock.
• This change is attributed to an internal realignment within The Vanguard Group, effective January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of Vanguard will report beneficial ownership separately, disaggregated from The Vanguard Group, Inc.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event for CareDx Inc. as the change in beneficial ownership is attributed to an internal administrative realignment within The Vanguard Group, rather than a strategic investment decision related to CareDx's performance.

Future Outlook

The filing primarily details an internal organizational change at The Vanguard Group regarding its beneficial ownership reporting structure. It does not provide any forward-looking statements or guidance related to CareDx Inc.'s business operations or financial performance.

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that changes in reported institutional ownership, particularly from large asset managers like The Vanguard Group, can sometimes signal shifts in investment sentiment. However, in this instance, the explicit mention of an internal realignment and disaggregated reporting suggests an administrative change rather than a strategic divestment based on CareDx Inc.'s performance or outlook. This type of internal restructuring leading to changes in reporting is not uncommon among large, diversified financial institutions.

Stakeholder Impact

• Shareholders of CareDx Inc. will observe a change in the reported institutional ownership structure, with The Vanguard Group, Inc. no longer reporting direct beneficial ownership.
• The impact is mitigated by the clear explanation that this is due to an internal realignment at Vanguard, not a change in investment thesis regarding CareDx.

Key Dates

Keywords

CareDx Inc., Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Ownership, SEC Filing, Internal Realignment